Published in Biotech Business Week, January 8th, 2007
Designed to control blood flow through blood vessels during peripheral endovascular procedures, GuardDOG is the industry's first occlusion system to offer a 0.035"-based guidewire with a CO(2)-filled occlusion balloon.
"Our customers have identified the need for a guidewire with a distal occlusion balloon that can easily control blood flow in the vessel while allowing the introduction and use of endovascular treatment tools," said Robert Dutcher, chairman, president and CEO of Possis Medical. "This first human use is the capstone of several years of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.